Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS
Abstract Background Several studies compared everolimus-eluting bioresorbable scaffolds (EE-BRS) with everolimus-eluting stents (EES), but only few assessed these devices in patients with diabetes mellitus. Aim To evaluate the safety and efficacy outcomes of all-comer patients with diabetes mellitus up to 2 years after treatment with EE-BRS or EES. Methods We performed a post hoc pooled analysis of patient-level data in diabetic patients who were treated with EE-BRS or EES in 3 prospective clinical trials: The ABSORB DM Benelux Study (NTR5447), TWENTE (NTR1256/NCT01066650) and DUTCH PEERS (NTR... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2020 |
Reihe/Periodikum: | Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020) |
Verlag/Hrsg.: |
BMC
|
Schlagwörter: | Bioresorbable scaffolds / Drug-eluting stents / Diabetes mellitus / Coronary artery disease / Percutaneous coronary intervention / Device thrombosis / Diseases of the circulatory (Cardiovascular) system / RC666-701 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27017105 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.1186/s12933-020-01116-2 |